Trilogy Metals (AMEX:TMQ) reported quarterly losses of $(0.03) per share. This is a 50 percent decrease over losses of $(0.02) per share from the same period last year.
BMO Capital Downgrades Graphite Bio to Market Perform, Lowers Price Target to $7
BMO Capital analyst Kostas Biliouris downgrades Graphite Bio (NASDAQ:GRPH) from Outperform to Market Perform and lowers the price target from $14 to $7.